High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Zhang, Yi An ^a   Zhu, Ji Min ^a   Yin, Jie ^a   Tang, Wen Qing ^a   Guo, Yan Mei ^b   Shen, Xi Zhong ^a   Liu, Tao Tao ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEURO ONCOLOGICAL VENTRAL ANTIGEN 1; TUMOR PROTEIN; UNCLASSIFIED DRUG; NOVA1 PROTEIN, HUMAN; RNA BINDING PROTEIN; SMALL INTERFERING RNA; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; SURVIVAL RATE; ANTAGONISTS AND INHIBITORS; CARCINOMA, HEPATOCELLULAR; CELL MOTION; FOLLOW UP; GENE EXPRESSION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; SURVIVAL; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84897498372     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090955     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Marrero JA, El-Serag HB (2011) Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology 53: 1060-1061; author reply 1061-1062.
3. Qin LX, Tang ZY (2004) Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol 130: 497-513.
4. Buckanovich RJ, Posner JB, Darnell RB (1993) Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 11: 657-672. (Pubitemid 23321775)
5. Kazarian M, Laird-Offringa IA (2011) Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer 10: 33.
6. Buckanovich RJ, Yang YY, Darnell RB (1996) The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci 16: 1114-1122. (Pubitemid 26140868)
7. Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543-1554. (Pubitemid 37255041)
8. Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, et al. (1986) Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 90: 263-267.
9. Sobin LH, Gospodarowicz MK, Wittekind C (2011) TNM classification of malignant tumours: Wiley. com.
10. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer 7: 462-503.
11. Li Y, Tang ZY, Ye SL, Liu YK, Chen J, et al. (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 7: 630-636. (Pubitemid 32994410)
12. Esteves CL, Kelly V, Begay V, Lillico SG, Leutz A, et al. (2013) Stable conditional expression and effect of C/ebpbeta-LIP in adipocytes using the pSLIK system. J Mol Endocrinol 51: 91-98.
13. Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, et al. (2012) SOX1 functions as a tumor suppressor by antagonizing the WNT/beta-catenin signaling pathway in hepatocellular carcinoma. Hepatology 56: 2277-2287.
14. Zheng L, Weilun Z, Minghong J, Yaxi Z, Shilian L, et al. (2012) Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice. BMC Cancer 12: 153.
15. Johnstone O, Lasko P (2001) Translational regulation and RNA localization in Drosophila oocytes and embryos. Annu Rev Genet 35: 365-406. (Pubitemid 34032981)
16. Tamburino AM, Ryder SP, Walhout AJ (2013) A Compendium of Caenor-habditis elegans RNA Binding Proteins Predicts Extensive Regulation at Multiple Levels. G3 (Bethesda) 3: 297-304.
17. Curtis D, Lehmann R, Zamore PD (1995) Translational regulation in development. Cell 81: 171-178.
18. Brieva-Ruiz L, Diaz-Hurtado M, Matias-Guiu X, Marquez-Medina D, Tarragona J, et al. (2008) Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study. Clin Neurol Neurosurg 110: 1044-1046.
19. Wirtz PW, Sillevis Smitt PA, Hoff JI, de Leeuw B, Lammers GJ, et al. (2002) Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma. J Neurol 249: 1710-1712. (Pubitemid 36269264)
20. Stich O, Rasiah C, Rauer S (2009) Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome. Acta Neurol Scand 119: 338-340.
21. Rahman J, Latal AT, Besser S, Hirrlinger J, Hulsmann S (2013) Mixed miniature postsynaptic currents resulting from co-release of glycine and GABA recorded from glycinergic neurons in the neonatal respiratory network. Eur J Neurosci.
22. Schwarz N, Drouot L, Nicke A, Fliegert R, Boyer O, et al. (2012) Alternative splicing of the N-terminal cytosolic and transmembrane domains of P2X7 controls gating of the ion channel by ADP-ribosylation. PLoS One 7: e41269.
23. Ganguly S, Basu B, Shome S, Jadhav T, Roy S, et al. (2010) Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Kruppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation. Am J Pathol 177: 2701-2707.
24. Sun D, Gong Y, Kojima H, Wang G, Ravinsky E, et al. (2003) Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth. Am J Physiol Gastrointest Liver Physiol 285: G12-19. (Pubitemid 36736383)
25. Wang T, Huang W, Chen F (2008) Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. Life Sci 82: 536-541.
26. Liu Y, Li YH, Guo FJ, Wang JJ, Sun RL, et al. (2008) Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. World J Gastroenterol 14: 7175-7182.
27. Lodewyks C, Rodriguez J, Yan J, Lerner B, Lipschitz J, et al. (2011) GABA-B receptor activation inhibits the in vitro migration of malignant hepatocytes. Can J Physiol Pharmacol 89: 393-400.